Company Presentations-Wednesday Afternoon Block

1:45 PM - 5:00 PM (EDT), Wednesday, June 7, 2023 ・ Session Rooms 103-104C
View 13-minute podium presentations across a wide range of therapeutic areas. Join us on Level 1 in Rooms 103, 104A, 104B, and 104C all four days of Convention.

Company Presentations are accessible to all registered attendees.
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company Website:
Not Provided
Company HQ State:
Not Provided
Company HQ Country:
Not Provided
Year Founded:
Not Provided
Main Therapeutic Focus:
Not Provided
Lead Product in Development:
Not Provided
Development Phase of Primary Product:
Not Provided
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
1:45 PM - 2:00 PM
Baiya Phytopharm is an Asia based biotech company established by a global leader in plant-based…
Session Room 103
Sinopia Biosciences is a biotechnology company leveraging a multi-omics powered AI/ML drug…
Session Room 104C
Enterome is a clinical stage company developing off-the-shelf, transformational cancer treatments…
Session Room 104A
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop…
Session Room 104B
2:00 PM - 2:15 PM
Synaffix BV is a biotech company that has established a proprietary, clinical-stage technology…
Session Room 103
ImmunoChem Therapeutics, a Phase 2 clinical stage, Northwestern University spin-out, is developing…
Session Room 104C
Galapagos is a fully integrated biotechnology company focused on discovering, developing and…
Session Room 104A
2:15 PM - 2:30 PM
Atomic AI is an emerging biotechnology company exploiting the fusion of artificial intelligence and…
Session Room 103
Courage Therapeutics is a pre-clinical biotech company focused on feeding behavior. The company has…
Session Room 104C
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for…
Session Room 104B
MAIA Biotechnology, Inc. is a targeted therapy, immune-oncology company, focused on development of…
Session Room 104A
2:30 PM - 2:45 PM
Synthego was founded to revolutionize genome engineering technology, helping translate genomics…
Session Room 103
Sensei Biotherapeutics (NASDAQ: SNSE) is an immuno-oncology company focused on the discovery and…
Session Room 104A
Vincere Biosciences is developing AI-derived mitochondrial targeted therapeutics with a mission to…
Session Room 104C
Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company,…
Session Room 104B
2:45 PM - 3:00 PM
IMUNON is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio…
Session Room 104A
Algen is a platform therapeutics and drug discovery company using the world’s leading CRISPR and AI…
Session Room 103
Praxis Bioresearch is an NIH Innovation Zone Company developing a novel treatment for behavioral…
Session Room 104C
Navigo Proteins is a fast-growing German biotech developing next-generation targeted therapeutics,…
Session Room 104B
3:00 PM - 3:15 PM
Lokon Pharma is a privately owned, Swedish biotech company developing immunostimulatory gene…
Session Room 104A
Guangzhou Magpie Pharmaceuticals, Inc. (MPI) is a clinical stage drug discovery and development…
Session Room 103
St. Jude Children's Research Hospital is a non-profit pediatric research institution. The mission…
Session Room 104C
3:15 PM - 3:30 PM
Macro Biologics’ innovative technology platform creates synthetic biological polymers (macro…
Session Room 104C
Rakuten Medical, Inc. is a global biotechnology company developing and commercializing precision,…
Session Room 104A
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next…
Session Room 103
Solaxa is a clinical-stage, bio-pharmaceutical, start-up company developing and commercializing…
Session Room 104B
3:30 PM - 3:45 PM
EmendoBio is a gene editing company with a diverse therapeutic pipeline based on proprietary…
Session Room 103
We are an innovative biopharmaceutical company developing and commercializing a pipeline of drug…
Session Room 104C
We are a clinical-stage biopharmaceutical company focused on the development of GP2, an…
Session Room 104A
MicuRx was founded by Dr. Zhengyu Yuan and Dr. Mikhail F. Gordeev, and is led by an experienced,…
Session Room 104B
3:45 PM - 4:00 PM
SAB Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of…
Session Room 104B
Cartherics is an Australian biotech company developing a range of allogeneic (off-the-shelf) immune…
Session Room 103
Kintara Therapeutics is a clinical stage drug development company with a focus on the development…
Session Room 104A
3:45 PM - 4:30 PM
LinusBio is a patient-centric, precision exposome medicine company, originating from the world’s…
Session Room 104C
4:00 PM - 4:15 PM
RheumaGen is developing a novel gene-editing therapy to cure rheumatoid arthritis (RA). RheumaGen’s…
Session Room 103
Affini-T is unlocking the power of T cells and targeting core oncogenic drivers to develop…
Session Room 104B
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to…
Session Room 104A
Bolden Therapeutics is a preclinical-stage biotechnology company developing first-in-class…
Session Room 104C
4:15 PM - 4:30 PM
Genesis Therapeutics has created the industry's most advanced molecular AI platform by combining…
Session Room 104C
ArtisanBio provides premiere genome engineering tools for cell and gene therapy companies looking…
Session Room 103
Like real-time traffic data revolutionized how we drive, Pepper Bio, the world’s first transomics…
Session Room 104A
Arpeggio makes medicine to alter gene expression and fight drug resistance in cancer. We do this by…
Session Room 104B
4:30 PM - 4:45 PM
At Avstera, our primary focus is to address the significant unmet need of cancer patients failing…
Session Room 104B
Umoja Biopharma, Inc. is a transformative in vivo CAR T and immuno-oncology company creating…
Session Room 103
CancerFree Biotech is a start-up company dedicated to personalized treatment of cancer. We…
Session Room 104A
FELIQS, a Japanese startup company funded with a seed round of $2.5 million, develops a portfolio…
Session Room 104C
4:45 PM - 5:00 PM
ViGeneron is based on our passion to deliver gene therapy innovations and advances to people in…
Session Room 103
NeoImmuneTech (NIT) is a T-cell Centric IO Company and the Global Leader in Interleukin (IL-7). At…
Session Room 104A